| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/14/2013 | US20130066069 Processes for preparing substituted pyrimidines |
| 03/14/2013 | US20130065941 Compositions and their uses for gene therapy of bone conditions |
| 03/14/2013 | US20130065934 Fatty acid cox inhibitor derivatives and their uses |
| 03/14/2013 | US20130065920 Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient |
| 03/14/2013 | US20130065902 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators |
| 03/14/2013 | US20130065899 Heteroaryl compounds and uses thereof |
| 03/14/2013 | US20130065882 VLA-4 inhibitory drug |
| 03/14/2013 | US20130065881 Tricyclic Compounds for Use as Kinase Inhibitors |
| 03/14/2013 | US20130065880 Compounds as tyrosine kinase modulators |
| 03/14/2013 | US20130065870 Treatment of pain with topical diclofenac |
| 03/14/2013 | US20130065861 Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc. |
| 03/14/2013 | US20130065860 3-(4-(5-phenyl-1 ,2,4-oxadiazol-3-yl)phenoxy)propan-2-ol derivatives as sphingosine-1 phosphate receptors modulators |
| 03/14/2013 | US20130065858 Compounds useful as raf kinase inhibitors |
| 03/14/2013 | US20130065842 COMPOUNDS AS RORyT MODULATORS AND USES THEREOF |
| 03/14/2013 | US20130065838 Sap variants and their use |
| 03/14/2013 | US20130065827 Crystalline Peptide Epoxyketone Immunoproteasome Inhibitor |
| 03/14/2013 | US20130065820 Synthetic myostatin peptide antagonists |
| 03/14/2013 | US20130065816 Analogs of pituitary adenylate cyclase-activating polypeptide (pacap) and methods for their use |
| 03/14/2013 | US20130064903 Rheumatiod arthritis cure |
| 03/14/2013 | US20130064891 Pharmaceutical compositions of nsaid and acid inhibitor |
| 03/14/2013 | US20130064863 Multicomponent and biocompatible nanocomposite materials, methods of synthesizing same and applications of same |
| 03/14/2013 | US20130064836 Compositions and Methods for Antibodies Targeting Complement Protein C5 |
| 03/14/2013 | US20130064830 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization |
| 03/14/2013 | US20130064829 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization |
| 03/14/2013 | US20130064827 Il-17 homologous polypeptides and thereapeutic uses thereof |
| 03/14/2013 | US20130064819 Biomarkers |
| 03/14/2013 | US20130064817 Engineered anti-il-23r antibodies |
| 03/14/2013 | US20130064816 TNF-alpha ANTAGONISTS AND METHOTREXATE IN THE TREATMENT OF TNF-MEDIATED DISEASE |
| 03/14/2013 | US20130064801 Cellular Compositions and Methods of Making and Using Them |
| 03/14/2013 | US20130064777 Surfactant-free water-free foamable compositions, breakable foams and gels their uses |
| 03/14/2013 | CA2848129A1 3-(4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenoxy)propan-2-ol derivatives as sphingosine-1 phosphate receptors modulators |
| 03/14/2013 | CA2847575A1 Method for increasing osteoblastic function |
| 03/13/2013 | EP2566861A1 Modulators of fatty acid amide hydrolase |
| 03/13/2013 | EP2566847A1 Novel immunomodulator and anti inflammatory compounds |
| 03/13/2013 | EP2566501A2 Method and device for transdermal delivery of parathyroid hormone using a microprojection array |
| 03/13/2013 | EP2566481A1 Aza-indole derivatives useful as modulators of faah |
| 03/13/2013 | EP2566471A2 Effects of the association of vitamin k2 and vitamin d3 in the consolidation of a bone fracture |
| 03/13/2013 | CN202777138U Medicine health maintaining lumbar vertebrae pillow |
| 03/13/2013 | CN102971424A High-affinity nucleic acid aptamers against sclerostin protein |
| 03/13/2013 | CN102971414A Treatment of bone fracture |
| 03/13/2013 | CN102971318A Tetrahydrocarboline derivative |
| 03/13/2013 | CN102971291A Novel amide derivative and use thereof as medicine |
| 03/13/2013 | CN102970989A Diclofenac salt of tramadol |
| 03/13/2013 | CN102965425A Medicament screening method, medicament used for promoting crosslink of extracellular matrix and application of medicament |
| 03/13/2013 | CN102965252A Healthcare wine for gout |
| 03/13/2013 | CN102964453A Osteogenic growth peptide-calcitonin gene related peptide fusion protein and encoding gene thereof |
| 03/13/2013 | CN102964452A msCT-rhLeptin fusion protein for treating osteoporosis and obesity and nucleic acid encoding fusion protein |
| 03/13/2013 | CN102964451A msCT-CTx fusion protein for treating osteoporosis and reliving pain and nucleic acid encoding fusion protein |
| 03/13/2013 | CN102964450A OGP-AcAP2 (Osteogenic Growth Peptide) fusion protein for treating osteoporosis and thrombus and nucleic acid for coding fusion protein |
| 03/13/2013 | CN102964347A 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments |
| 03/13/2013 | CN102964264A Preparation method of natural general alkaloids of capsicum annuum |
| 03/13/2013 | CN102961785A Tumor cavity filler for treating giant cell tumor of bone and preparation method thereof |
| 03/13/2013 | CN102961746A Use of tnf inhibitor for treatment of erosive polyarthritis |
| 03/13/2013 | CN102961727A Traditional Chinese medicine composition for treating bone diseases in clinical nursing |
| 03/13/2013 | CN102961647A Traditional Chinese medicine for treating osteoporosis |
| 03/13/2013 | CN102961616A Chinese drug agentia for treating osteoproliferation |
| 03/13/2013 | CN102961610A Topical paste patch |
| 03/13/2013 | CN102961557A Aqueous compound peganum harmala pharmaceutical composition and preparation method thereof |
| 03/13/2013 | CN102961550A Traditional Chinese medicine for treating gout disease |
| 03/13/2013 | CN102961547A Tripterygium wilfordii wind expelling soup |
| 03/13/2013 | CN102961544A Traditional chinese medicine bedsore powder |
| 03/13/2013 | CN102961539A Plaster for treating wind-cold-dampness arthralgia and preparation method thereof |
| 03/13/2013 | CN102961531A Chinese medicament for treating neck, shoulder, waist and leg pains and hyperostosis |
| 03/13/2013 | CN102961527A Traditional Chinese medicine for treating lumbar disc herniation |
| 03/13/2013 | CN102961520A Pharmaceutical composition for treating arthritis and method for preparing pharmaceutical composition for treating arthritis |
| 03/13/2013 | CN102961518A Application for ginseng-rhizoma curculiginis combined medicine for preparation for medicine used for treating osteoporosis |
| 03/13/2013 | CN102961509A Traditional Chinese medicine for treating hemiplegia |
| 03/13/2013 | CN102961507A Medicinal liquor prepared by soaking natural traditional Chinese medicine for treating rheumatism and preparation method thereof |
| 03/13/2013 | CN102961494A Plaster for treating lumbar hyperosteogeny |
| 03/13/2013 | CN102961459A Traditional Chinese medicine composition for treating joint swelling and pain and preparation method thereof |
| 03/13/2013 | CN102961455A Chinese herbal powder for treating lumbar disc herniation and using method thereof |
| 03/13/2013 | CN102961454A Method for treating scapulohumeral periarthritis and preparation method for same |
| 03/13/2013 | CN102961438A Traditional Chinese medicine composition for treating rheumatism and rheumatoid arthritis and preparation method thereof |
| 03/13/2013 | CN102961434A Eremias electuary for treating cerebral hemorrhage and preparation method thereof |
| 03/13/2013 | CN102961429A Traditional Chinese medicine formula for osteoproliferation |
| 03/13/2013 | CN102961419A Rattan notoginseng tincture and preparation method thereof |
| 03/13/2013 | CN102961415A Application of phellinus lonicericola or extract thereof |
| 03/13/2013 | CN102961389A Composition containing glucosamine as well as preparation method and detection method thereof |
| 03/13/2013 | CN102961339A Preparation method of sustained release preparation containing ibuprofen mini-pills |
| 03/13/2013 | CN102961249A Plan for treating arthralgia |
| 03/13/2013 | CN102429897B Pharmaceutical composition for improving oral bioavailability of morin |
| 03/13/2013 | CN102423323B Compound medicine for treating rheumatism and preparation method thereof |
| 03/13/2013 | CN102397523B Medicament for treating rheumatism and rheumatoid arthritis and pain in the neck, shoulders, waist and legs |
| 03/13/2013 | CN102335246B Composition of Chinese medicinal herbs for treating bone spurs |
| 03/13/2013 | CN102327408B Medicament for treating osteoporosis |
| 03/13/2013 | CN102319339B Chinese medicinal composition for treating senile fracture |
| 03/13/2013 | CN102225205B Tripterine nano structure lipid carrier and preparation method and application thereof |
| 03/13/2013 | CN102225108B Medicinal liquor for treating lumbago and protrusion of lumbar vertebral disc |
| 03/13/2013 | CN102188555B Health-care wine for treating rheumatism |
| 03/13/2013 | CN102166263B Compound preparation for treating cervical spondylotic myelopathy and preparation method thereof |
| 03/13/2013 | CN102078394B Aconite extract-containing medicinal composition, preparation method and application thereof |
| 03/13/2013 | CN102018963B MiR-125a for adjusting regulated on activation normal T cell expressed and secreted (RANTES) expressions as well as composition and application thereof |
| 03/13/2013 | CN101984983B Detection method of Lamiophlomis rotata extract, medicine composition containing the extract |
| 03/13/2013 | CN101851278B B cell activating factor antagonist as well as preparation method and application thereof |
| 03/13/2013 | CN101780129B Method for extracting active ingredients of Mongolian medicament echinops latifolius |
| 03/13/2013 | CN101721402B Treating bone-related disorders with selective androgen receptor modulators |
| 03/13/2013 | CN101601796B Chinese medicinal fuming-steaming composition for treating arthralgia syndrome, and guiding medicament thereof |
| 03/13/2013 | CN101600724B Nk1 receptor antagonist composition |
| 03/12/2013 | US8394930 Growth factor isoform |
| 03/12/2013 | US8394799 Compounds that inhibit HIF-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component |